Ifg Advisory, LLC Biomarin Pharmaceutical Inc Transaction History

Ifg Advisory, LLC

  • $1.75 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 26, 2018
SELL
$77.67 - $92.63 $185,941 - $221,756
-2,394 Closed
0 $0
Q4 2017

Feb 01, 2018
SELL
$80.76 - $95.13 $62,669 - $73,820
-776 Reduced 24.48%
2,394 $213,000
Q4 2017

Jan 29, 2018
BUY
$80.76 - $95.13 $256,009 - $301,562
3,170
3,170 $212,000

Others Institutions Holding BMRN

# of Institutions
626
Shares Held
183M
Call Options Held
2M
Put Options Held
1.67M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email